PRINCETON, New Jersey, January 7 /PRNewswire/ --

- 85% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg and Pegasys(R) plus Copegus(R) with safety and tolerability comparable to placebo -

- Conference Call Scheduled for 4:00PM ET Today -

LAS VEGAS, CES, January 7 /PRNewswire/ --

- Marvell 88DE2710 Digital Video Format Converter Powers Premium Quality Video on LCD Televisions

Marvell (Nasdaq: MRVL) today announced that its award-winning Qdeo(TM) video processing is a featured technology of the Onida 42" Xaria LCD-TV, developed for the emerging markets of India and the Gulf countries. Part of the Marvell(R) 88DE2710 digital video format converter, Qdeo delivers quiet, natural video free of artifacts and noise, enhances the color, and intelligently scales all video inputs into a high-definition format.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW167LOGO)

BASEL, Switzerland, January 7 /PRNewswire/ --

- For non US or non UK Media Only

- Oral Chemotherapy Tablet Option Reduces the Time Patients Need to Spend in the Hospital

Data recently published in the New England Journal of Medicine confirm oral chemotherapy tablet Xeloda (capecitabine) as a first-line treatment for advanced stomach cancer. The publication reinforces the drug's use for this difficult-to-treat disease, enabling clinicians to prescribe Xeloda in combination with platinum-based chemotherapy. Stomach cancer is the fourth most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide(1.). Annually, there are an estimated 911,000 deaths worldwide(2.), with nearly 140,000 deaths in Europe alone(3.).

WASHINGTON, January 7 /PRNewswire/ --

- Investment in Ocean & Oil is ECP's Fifth in African Oil and Gas Sector

HEILBRONN, Germany, January 7 /PRNewswire/ --

Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the highly integrated broadcast radio front end IC ATR4262, which enables outstanding car-radio reception. The new IC is designed for high performance applications, in particular for mobile systems such as car radios. The ATR4262 is compatible with the major radio standards including HD Radio, DRM, and AM/FM.

The ATR4262 is a world tuner device covering all AM/FM frequencies worldwide. Its FM section handles the frequency range from 70 MHz to 166 MHz, including weather band and HD Radio in the US. The AM path covers the entire broadcasting frequency range from 150 kHz up to 30 MHz, including modern DRM systems.

LA JOLLA, California, January 7 /PRNewswire/ --

DermTech, Inc., a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, announced that it has entered into an agreement with Stiefel Laboratories, Inc., the largest, privately owned, dermatology company in the world. The two companies will work together using DermTech's patented EGIR technology and proprietary gene expression assays to identify and further understand the genes involved in causing acne. It is envisioned that data from the feasibility study may be used by Stiefel Laboratories in the development of targeted products to treat this widespread skin condition.